Alison J. Gareau

469 total citations
21 papers, 341 citations indexed

About

Alison J. Gareau is a scholar working on Transplantation, Surgery and Immunology. According to data from OpenAlex, Alison J. Gareau has authored 21 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Transplantation, 9 papers in Surgery and 8 papers in Immunology. Recurrent topics in Alison J. Gareau's work include Renal Transplantation Outcomes and Treatments (12 papers), Transplantation: Methods and Outcomes (8 papers) and Immune Cell Function and Interaction (5 papers). Alison J. Gareau is often cited by papers focused on Renal Transplantation Outcomes and Treatments (12 papers), Transplantation: Methods and Outcomes (8 papers) and Immune Cell Function and Interaction (5 papers). Alison J. Gareau collaborates with scholars based in Canada, United States and Netherlands. Alison J. Gareau's co-authors include Michael Bezuhly, Brent Johnston, Simon Gebremeskel, Chris Wiebe, Ian W. Gibson, Robert Liwski, Peter Nickerson, David N. Rush, Julie Ho and Denise Pochinco and has published in prestigious journals such as Frontiers in Immunology, Plastic & Reconstructive Surgery and Transplantation.

In The Last Decade

Alison J. Gareau

21 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison J. Gareau Canada 10 171 145 116 62 45 21 341
Massimo Mangiola United States 13 236 1.4× 230 1.6× 92 0.8× 76 1.2× 87 1.9× 29 467
Keisuke Minamimura Japan 9 36 0.2× 91 0.6× 160 1.4× 68 1.1× 40 0.9× 33 316
Emma L. Lagaaij Netherlands 9 193 1.1× 220 1.5× 139 1.2× 33 0.5× 121 2.7× 11 531
Eliano Bonaccorsi‐Riani Belgium 14 246 1.4× 360 2.5× 67 0.6× 81 1.3× 45 1.0× 32 607
Eduardo Vázquez‐Martul Spain 5 61 0.4× 71 0.5× 173 1.5× 14 0.2× 26 0.6× 10 284
Maria Edvige Fasano Italy 9 29 0.2× 69 0.5× 69 0.6× 49 0.8× 51 1.1× 15 375
Maria L. Espejo United States 6 262 1.5× 411 2.8× 117 1.0× 85 1.4× 39 0.9× 10 501
Lindsey Fitzgerald United States 6 33 0.2× 78 0.5× 176 1.5× 105 1.7× 33 0.7× 25 359
Valentina Portalupi Italy 8 42 0.2× 47 0.3× 119 1.0× 14 0.2× 39 0.9× 12 259
Kang Zhou China 10 20 0.1× 64 0.4× 60 0.5× 39 0.6× 23 0.5× 68 290

Countries citing papers authored by Alison J. Gareau

Since Specialization
Citations

This map shows the geographic impact of Alison J. Gareau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison J. Gareau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison J. Gareau more than expected).

Fields of papers citing papers by Alison J. Gareau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison J. Gareau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison J. Gareau. The network helps show where Alison J. Gareau may publish in the future.

Co-authorship network of co-authors of Alison J. Gareau

This figure shows the co-authorship network connecting the top 25 collaborators of Alison J. Gareau. A scholar is included among the top collaborators of Alison J. Gareau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison J. Gareau. Alison J. Gareau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gareau, Alison J., et al.. (2024). HLA Genotype Imputation Results in Largely Accurate Epitope Mismatch Risk Categorization Across Racial Groups. Transplantation Direct. 10(7). e1639–e1639. 4 indexed citations
2.
Xu, Qingyong, Mohamed Elrefaei, Jean‐Luc Taupin, et al.. (2023). Chronic lung allograft dysfunction is associated with an increased number of non-HLA antibodies. The Journal of Heart and Lung Transplantation. 43(4). 663–672. 8 indexed citations
3.
Krummey, Scott M. & Alison J. Gareau. (2022). Donor specific HLA antibody in hematopoietic stem cell transplantation: Implications for donor selection. Frontiers in Immunology. 13. 916200–916200. 18 indexed citations
4.
Gareau, Alison J., et al.. (2022). Next‐generation sequencing identifies two novel HLA class II alleles, HLA‐DRB1*01:115 and HLA‐DRB1*14:224. HLA. 100(2). 176–177. 1 indexed citations
5.
Gareau, Alison J., et al.. (2021). Four novel HLA class II alleles identified using next‐generation sequencing. HLA. 98(3). 233–234. 2 indexed citations
6.
LeVatte, Terry L., et al.. (2020). The Selective Angiotensin II Type 2 Receptor Agonist Compound 21 Reduces Abdominal Adhesions in Mice. Journal of Surgical Research. 256. 231–242. 10 indexed citations
7.
Gareau, Alison J., et al.. (2019). Identification of a novel HLA‐C allele, HLA‐C*07:778, in an unrelated hematopoietic stem cell donor. HLA. 94(2). 161–162. 2 indexed citations
8.
Gareau, Alison J., et al.. (2019). The identification of a novel HLA‐B allele, HLA‐B*27:05:38. HLA. 94(2). 157–158. 3 indexed citations
9.
Gareau, Alison J., et al.. (2019). OR39 Public solicitation for a living kidney donor: Effects on the transplant waiting list and HLA laboratory workload. Human Immunology. 80. 45–45. 1 indexed citations
10.
Gareau, Alison J., et al.. (2018). Ticagrelor inhibits platelet–tumor cell interactions and metastasis in human and murine breast cancer. Clinical & Experimental Metastasis. 35(1-2). 25–35. 74 indexed citations
11.
Gebremeskel, Simon, et al.. (2018). Promotion of Primary Murine Breast Cancer Growth and Metastasis by Adipose-Derived Stem Cells Is Reduced in the Presence of Autologous Fat Graft. Plastic & Reconstructive Surgery. 143(1). 137–147. 16 indexed citations
12.
Gareau, Alison J., et al.. (2017). Effect of Compound 21, a Selective Angiotensin II Type 2 Receptor Agonist, in a Murine Xenograft Model of Dupuytren Disease. Plastic & Reconstructive Surgery. 140(5). 686e–696e. 16 indexed citations
13.
Gareau, Alison J., Chris Wiebe, Denise Pochinco, et al.. (2017). Pre-transplant AT 1 R antibodies correlate with early allograft rejection. Transplant Immunology. 46. 29–35. 44 indexed citations
14.
Wiebe, Chris, Alison J. Gareau, Denise Pochinco, et al.. (2016). Evaluation of C1q Status and Titer of De Novo Donor-Specific Antibodies as Predictors of Allograft Survival. American Journal of Transplantation. 17(3). 703–711. 63 indexed citations
15.
Huibers, Manon M. H., Alison J. Gareau, Joyce van Kuik, et al.. (2016). Donor-Specific Antibodies Are Produced Locally in Ectopic Lymphoid Structures in Cardiac Allografts. American Journal of Transplantation. 17(1). 246–254. 23 indexed citations
16.
Huibers, Manon M. H., Alison J. Gareau, Aryan Vink, et al.. (2014). The composition of ectopic lymphoid structures suggests involvement of a local immune response in cardiac allograft vasculopathy. The Journal of Heart and Lung Transplantation. 34(5). 734–745. 26 indexed citations
17.
Rosin, Nicole L., et al.. (2014). Antibody therapy can enhance AngiotensinII-induced myocardial fibrosis. PubMed. 7(1). 6–6. 2 indexed citations
18.
Gareau, Alison J., et al.. (2014). De novo alloreactive memory CD8+ T cells develop following allogeneic challenge when CNI immunosuppression is delayed. Transplant Immunology. 32(1). 23–28. 1 indexed citations
19.
Gareau, Alison J., Björn Nashan, Gregory M. Hirsch, & Timothy D.G. Lee. (2012). Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathy. The Journal of Heart and Lung Transplantation. 31(8). 874–880. 4 indexed citations
20.
Gareau, Alison J., et al.. (2009). Contribution of B Cells and Antibody to Cardiac Allograft Vasculopathy. Transplantation. 88(4). 470–477. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026